| abstract |
The present application provides a general formula I ′ (wherein A, Q, X, Y, Z 1 , Z 2 , m, p, q, z, m, R 1 , R useful for the treatment of diseases associated with monoamine deficiency. 1 ' , R 2 , R 3 , and R 4 are defined as described herein) or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions, methods of use, and methods of making the compounds. |